Strata Skin Sciences, Inc. (SSKN) financial statements (2022 and earlier)

Company profile

Business Address 5 WALNUT GROVE DRIVE
HORSHAM, PA 19044
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12,58610,6048,12916,4874,0693,9283,303
Cash and cash equivalents12,58610,6048,12916,4874,0693,9283,303
Restricted cash and investments 7,5087,500   15
Receivables3,4332,9444,3863,3933,1413,3904,068
Inventory, net of allowances, customer advances and progress billings3,4893,4443,0272,7943,0092,8174,128
Inventory3,4893,4443,0272,7943,0092,8174,128
Other undisclosed current assets462331513536533617465
Total current assets:19,97024,83123,55523,21010,75210,75211,979
Noncurrent Assets
Operating lease, right-of-use asset6389881,314
Property, plant and equipment6,8835,5295,3695,3017,70310,18013,851
Intangible assets, net (including goodwill)18,88615,14816,75818,56820,12822,21524,155
Goodwill8,8038,8038,8038,8038,8038,8038,928
Intangible assets, net (excluding goodwill)10,0836,3457,9559,76511,32513,41215,227
Deferred costs      1,293
Other noncurrent assets216282347428484694
Total noncurrent assets:26,62321,94723,78824,29727,87932,44139,393
TOTAL ASSETS:46,59346,77847,34347,50738,63143,19351,372
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,1997,4547,0146,2644,6373,8456,607
Accounts payable2,8222,7641,8801,7642,2771,8534,446
Accrued liabilities6,3774,6905,1344,5002,3601,9922,161
Deferred revenue3,2852,2622,8322,099
Debt 8,7533132522,3871,714 
Deferred revenue and credits291235173
Other undisclosed current liabilities3183697,275 357339299
Total current liabilities:12,80218,83817,4348,6157,6726,1337,079
Noncurrent Liabilities
Long-term debt and lease obligation7,7111,7601,0787,1457,8539,75210,179
Long-term debt, excluding current maturities7,3191,050 7,1457,8539,75210,179
Operating lease, liability3927101,078
Liabilities, other than long-term debt3002881783888615747,281
Accounts payable and accrued liabilities20    1358
Deferred revenue14  
Deferred tax liabilities, net 414359119
Deferred income tax liabilities266254 
Other liabilities 341783884449762
Derivative instruments and hedges, liabilities    31057,042
Other undisclosed noncurrent liabilities366  111 12,01510,746
Total noncurrent liabilities:8,3772,0481,2567,6448,71422,34128,206
Total liabilities:21,17920,88618,69016,25916,38628,47435,285
Stockholders' equity
Stockholders' equity attributable to parent, including:25,41425,89228,65331,24822,24514,71916,087
Preferred stock     11
Common stock3434333041110
Additional paid in capital247,059244,831243,180241,988251,643225,280223,315
Accumulated other comprehensive income     21
Accumulated deficit(221,679)(218,973)(214,561)(210,771)(229,406)(210,575)(207,240)
Other undisclosed stockholders' equity attributable to parent  114  
Total stockholders' equity:25,41425,89228,65331,24822,24514,71916,087
TOTAL LIABILITIES AND EQUITY:46,59346,77847,34347,50738,63143,19351,372

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues29,97723,09031,58629,85531,44931,75718,495
Revenue, net31,44931,75718,495
Cost of revenue(10,127)(8,956)(11,316)(12,735)(13,498)(12,636)(13,719)
Cost of goods and services sold      (4,818)
Gross profit:19,85014,13420,27017,12017,95119,1214,776
Operating expenses(24,252)(18,210)(23,280)(20,475)(20,361)(22,718)(21,251)
Operating loss:(4,402)(4,076)(3,010)(3,355)(2,410)(3,597)(16,475)
Nonoperating income (expense)1,730(61)(929)(942)(16,292)2133
Other nonoperating income   200172133
Interest and debt expense2,029 (414)(1,142)(11,799)(4,900)(10,200)
Other undisclosed income from continuing operations before equity method investments, income taxes  4141,14211,7995,3961,814
Loss from continuing operations before equity method investments, income taxes:(643)(4,137)(3,939)(4,297)(18,702)(3,080)(24,828)
Other undisclosed loss from continuing operations before income taxes(2,029)      
Loss from continuing operations before income taxes:(2,672)(4,137)(3,939)(4,297)(18,702)(3,080)(24,828)
Income tax expense (benefit)(34)(275)149264(129)(255)(119)
Net loss attributable to parent:(2,706)(4,412)(3,790)(4,033)(18,831)(3,335)(24,947)
Preferred stock dividends and other adjustments      (2,962)
Other undisclosed net income available to common stockholders, basic  1931,124   
Net loss available to common stockholders, basic:(2,706)(4,412)(3,597)(2,909)(18,831)(3,335)(27,909)
Interest on convertible debt    3,117  
Other undisclosed net loss available to common stockholders, diluted     (5,396) 
Net loss available to common stockholders, diluted:(2,706)(4,412)(3,597)(2,909)(15,714)(8,731)(27,909)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(2,706)(4,412)(3,790)(4,033)(18,831)(3,335)(24,947)
Comprehensive loss:(2,706)(4,412)(3,790)(4,033)(18,831)(3,335)(24,947)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (2)1(2,961)
Comprehensive loss, net of tax, attributable to parent:(2,706)(4,412)(3,790)(4,033)(18,833)(3,334)(27,908)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: